It involves growing bacteria such as Propionibacterium freudenreichii under controlled environment
Tribulus is high in compounds known as steroidal saponins, including protodioscin, which is thought to contribute to its therapeutic properties
This was Citius second try for FDA approval, after the regulator rejected Lymphir in July 2023, outlining the need for enhanced product resting requirements. In its resubmitted data package, the company included findings from the from the Phase III Study 302 trial, where treatment with the drug led to an objective response rate of 36.2%, with 8.7% reaching complete response
Duran M, Loof NE, Ketting D, Dorland L
For the therapy to achieve broader clinical acceptance, the establishment of standardized guidelines is paramount